4.6 Article

RAP2A promotes apoptosis resistance of hepatocellular carcinoma cells via the mTOR pathway

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies

Xinjun Lu et al.

Summary: Primary liver cancers, including HCC and iCCA, are highly lethal tumors with limited treatment options. The mTOR complex is a central regulator of cell growth and metabolism and plays a key role in liver-tumor development and progression. Current research aims to develop more effective mTOR inhibitors for liver-cancer treatment.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma

Yuan-Deng Luo et al.

Summary: This study found that p53 haploinsufficiency facilitates mTOR signaling, promoting HCC tumorigenesis and lung metastasis. Inhibition of PI3K/Akt reduces mTOR activity, and rapamycin significantly reduces hepatocarcinogenesis triggered by Tsc1 loss and p53 haploinsufficiency.

JOURNAL OF HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma

Gustavo Ferrin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, Research & Experimental

Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma

Jialei Weng et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2020)

Article Medicine, Research & Experimental

Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma

Lili Qu et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway?

Xiang-Nan Yu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Article Oncology

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4

Meng-Xuan Zhu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Oncology

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

J. Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Multidisciplinary Sciences

RAP2 mediates mechanoresponses of the Hippo pathway

Zhipeng Meng et al.

NATURE (2018)

Article Cell Biology

Over-expression of Rap2a inhibits glioma migration and invasion by down-regulating p-AKT

Lei Wang et al.

CELL BIOLOGY INTERNATIONAL (2014)

Article Endocrinology & Metabolism

Rap2 regulates androgen sensitivity in human prostate cancer cells

Dora Bigler et al.

PROSTATE (2007)

Article Biochemistry & Molecular Biology

Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade

Y Ohba et al.

MOLECULAR AND CELLULAR BIOLOGY (2000)